Regulating Biotechnology
for a Safer Ghana
Ensuring the safe transfer, handling, and use of genetically modified organisms across all sectors.
Learn MoreBiotech Biosafety Expo
Upholding Regulatory Excellence in Ghana
Established under the Biosafety Act, 2011 (Act 831), the National Biosafety Authority (NBA) is the apex regulator for modern biotechnology. Our work bridges the gap between scientific advancement and the protection of our environmental and public health assets.
Our Corporate Mission
To ensure an adequate level of protection in the safe transfer, handling, and use of Genetically Modified Organisms (GMOs) that may have an adverse effect on health and environment.
Key Regulatory Functions
Our Regulatory Pathways
Contained Use & Confined Field Trials
We evaluate, authorize, and monitor research activities involving Genetically Modified Organisms (GMOs) conducted within secure laboratory containment, greenhouses, or controlled field trial plots prior to environmental release.
The Regulatory Workflow
Our structured approach ensures that every biotechnology activity in Ghana undergoes a transparent and scientifically sound evaluation.
Application
Submission of biotech or GMO applications for review via our regulatory portal.
Scientific Review
Rigorous risk assessment by our technical committee to ensure environmental safety.
Decision Making
Based on scientific data, the Board grants approvals or requests modifications.
Monitoring
Post-approval inspection and compliance checks to ensure all standards are met.
Latest News & Publications
National Public Sensitization
on Modern Biotechnology
As part of our core mandate, the NBA is rolling out a nationwide education campaign to provide fact-based, scientifically accurate information regarding Genetically Modified Organisms (GMOs) to the Ghanaian public.